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Abstract
Introduction
Vestibular schwannomas (VS) are the most common benign neoplasms of a cerebellopontine
angle (CPA), which arise from the Schwann cells of the vestibulocochlear nerve. Eighty percent
of CPA tumors are VS followed by meningioma as the second common mass lesion in this
critical potential space. Treatment options range from watchful waiting with serial imaging
studies to radiosurgery or a microsurgical excision or a combination of surgery and radiation
therapy. The primary objective of the study was to assess hearing and facial nerve status before
and after the surgery via the retrosigmoid approach.
Methods
The database of Aga Khan University Hospital was searched for diagnoses of vestibular
schwannomas between 2000 and 2007. A total of 35 patients were identified; among them, 27
were selected for the study who met the inclusion criteria. The variables of the study were age,
gender, presenting symptoms, size of the tumor, surgical approach, hearing levels, and facial
nerve function. Hearing loss was categorized according to the Gardener-Robertson hearing
classification and the House-Brackmann Scale was used for facial nerve assessment.
Results
Out of the 27 patients, 18 were male and nine were female. The mean age was 43 years. The
most common presenting complaint was hearing loss and tinnitus, seen in 21 patients.
Headache was present in six patients, ataxia in five, and vertigo in three. Facial nerve weakness
was noticed in six patients. Two patients had Grade-III paralysis, three had Grade-IV paralysis,
and one had Grade-V paralysis. The audiogram confirmed the presence of sensorineural
hearing loss (SNHL) in all patients. Twelve patients out of 27 had Class II hearing with the
threshold between 31 and 50 decibels and a Speech Discrimination Score (SDS) of 50% to 69%.
Ten patients had non-serviceable hearing and the remaining five had poor hearing. The
audiogram was repeated after surgery for those 12 patients who had Class II hearing and
showed that seven out of 12 patients maintained a hearing threshold within the range of Class
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II at the one-year follow-up (hearing preservation 58%). The facial nerve preservation rate was
56% considering House-Brackmann Grade III or less as acceptable facial nerve function.
Conclusion
The optimal treatment for small vestibular schwannomas is a matter of controversy; however,
the choice of treatment for large vestibular schwannomas in patients without significant
comorbidity is generally microsurgical excision. The surgical excision of a large VS with the
retrosigmoid approach is found to be safe consistently. The hearing and facial nerve
preservation in our study were found comparable with the literature.
Categories: Otolaryngology, Neurosurgery
Keywords: vestibular schwannoma, acoustic neuroma, retrosigmoid craniotomy, retrosigmoid
approach, hearing preservation, cerebellopontine angle, schwannoma
Introduction
Vestibular schwannomas (VS) are benign neoplasms that arise from the myelin sheath of the
eighth cranial nerve. They account for 8% of all intracranial tumors and 80% of
cerebellopontine angle tumors [1]. Treatment options include microsurgery, fractionated
stereotactic radiotherapy, stereotactic radiosurgery, and a combination of surgery and
radiotherapy or observation [2]. The goals of VS management have shifted from surgical
excision to functional preservation, particularly when the removal of the tumor is not
considered safe in terms of cranial nerve preservation [3-4]. Studies have shown that the
function of the facial nerve is compromised in attempts of gross total removal of a large VS [5-
6]. Depending on many factors, including patient age, tumor size, growth, and
symptomatology, patients can choose surgery, radiation, or conservative management [7].
More than 90% of the cases are unilateral and present at a median age of 50 years. Patients
usually present with unilateral hearing loss and tinnitus. Pure tone audiometry reveals
asymmetric sensorineural hearing loss. Loss of speech discrimination score is out of proportion
to the hearing impairment and this prompts further investigation with magnetic resonance
imaging (MRI) of the internal auditory canal. Symptomatology is a function of cranial
neuropathies that result due to direct pressure as the tumor grows. The average growth rate of
vestibular schwannomas ranges from 2 mm to 4 mm per year in 50% of the cases, whereas less
than 10% can regress [8]. The extramural tumors are more likely to grow than those located
within the internal auditory canal [9]. Tumor expansion in the cerebellopontine angle causes a
compression of the brainstem and leads to life-threatening neurological complications.
Generally, small to medium-sized tumors that are less than 3 cm can be managed differently
from the large vestibular schwannomas. Surgery is the favored option over stereotactic
radiation therapy for large vestibular schwannomas. Some of the authors reported the
successful treatment of a large VS with stereotactic radiation therapy [10]. However, others
believe that radiation therapy may risk ischemia of the seventh cranial nerve and brainstem
compression with the consequent complications [11-12]. The optimal treatment, particularly
for a small to medium-sized tumor, remains controversial and the choice of modality of
treatment remains at the discretion of the treating physician and available resources.
Therefore, the approach to the patient is variable from center to center. The symptomatic
younger patients, particularly those with persistent dizziness, with anatomically favorable
tumors and a good hearing level, are offered gross total resection and also those with larger
tumors and a mass effect on the brain stem [12].
The preservation of hearing and facial nerve function has always been an important
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consideration in the management of VS. The current study was conducted at the Aga Khan
University Hospital, which is a tertiary care referral center in the city of Karachi, Pakistan. The
primary objective of the study was to assess hearing and facial nerve status before and after the
surgery via the retrosigmoid approach.
Materials And Methods
The database of Aga Khan University Hospital (AKUH) was searched for the diagnosis of
vestibular schwannoma between 2000 and 2007. Total 35 patients were identified among them
27 were selected for the study and the remaining eight patients were excluded because they
either had previous surgery outside AKUH or radiation therapy or the data required for the
study was not adequately available.
Review of the medical records including physician’s notes, imaging study and audiograms were
carried out. The variables of the study were age, gender, presenting symptoms, size of the
tumor, surgical approach, hearing levels, and facial nerve function. The hearing loss was
categorized according to the Gardener-Robertson hearing classification, as shown in Table 1
[13].
Class Description Audiogram Speech Discrimination Score
I Good/excellent 0 – 30 70% – 100%
II Serviceable 31 – 50 50% – 69%
III Non-serviceable 51 – 90 5% – 49%
IV Poor 91 max 1 – 4%
V None Not testable 0
TABLE 1: Gardener-Robertson classification of hearing
Preoperative and postoperative facial nerve status were assessed with the House-Brackmann
grading system as shown in Table 2 [14].
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SCALE Description
Grade I Normal
Grade II Noticeable on close inspection
Grade III Obvious but not disfiguring
Grade IV Disfiguring
Grade V Barely perceptible movement
Grade VI Complete paralysis
TABLE 2: House-Brackmann scale
Results
Out of 27 patients, 18 were male and nine were female. The mean age was 43 years. The most
common presenting complaint was hearing loss and tinnitus, seen in 21 patients. Headache
was present in six patients, ataxia in five, and vertigo in three. Facial nerve weakness was
noticed in six patients. Two patients had Grade-III paralysis, three had Grade-IV paralysis and
one had Grade-V paralysis. Twenty-one patients had normal facial nerve function at
presentation. Clinical presentation is shown in Table 3.
Clinical Feature Number of Patients
Hearing Loss 21
Tinnitus 21
Headache 6
Ataxia 5
Vertigo 3
Facial Palsy 6
TABLE 3: Clinical presentation of the patients
The audiogram confirmed the presence of sensorineural hearing loss (SNHL) in all patients.
SNHL was also seen on audiogram in those patients who did not report a hearing loss at the
time of presentation. According to the Gardner-Robertson hearing classification, 12 patients
out of 27 patients had serviceable hearing with a hearing threshold between 31 and 50 decibels
and Speech Discrimination Score (SDC) 50% to 69%. Ten patients had a non-serviceable
hearing and remaining five had poor hearing. All patients were investigated with contrast-
enhanced MRI, which revealed large vestibular schwannoma in the cerebellopontine angle. The
size of the tumor was reported between 3 cm to 4 cm in six patients and more than 4 cm in 21
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patients.
All patients were treated surgically with the retrosigmoid craniotomy approach by
neurosurgeons. The audiogram was repeated after surgery for those 12 patients who had
preoperative serviceable hearing (Class II). The postoperative audiogram showed seven out of
12 patients maintained a hearing threshold within the range of Class II at the one-year follow-
up (hearing preservation 58%). Study variables and results are shown in Table 4.
Variables Results
Gender Male = 18, Female = 9
Mean age 43 years
Preoperative serviceable hearing 12 patients
Postoperative serviceable hearing 7 patients
Tumor size 3 to 4 cm 6 patients
Tumor size >4 cm 21 patients
TABLE 4: Variables and results
The facial nerve function assessment at the one-year follow-up was noted as Grade I in five
patients, Grade II in three patients, Grade III in five patients, Grade IV in 10 patients, and Grade
V in four patients. Preoperative and postoperative facial nerve status is shown in Table 5.
 Grade I Grade II Grade III Grade IV Grade V
Preoperative 21 0 2 3 1
Postoperative 5 3 5 10 4
TABLE 5: Preoperative and postoperative facial nerve function according to the
House-Brackmann grading scale
The facial nerve preservation rate was 56% considering House-Brackmann Grade III or less as
acceptable facial nerve function.
Discussion
The management of vestibular schwannomas is a matter of debate, particularly for small
tumors that are less than 2 cm in size. The larger and symptomatic tumors are generally
considered for microsurgical excision except in cases with significant comorbidities
complicating open surgery [15]. The utmost goal of surgery for vestibular schwannomas in
patients with serviceable hearing is to achieve complete resection with the preservation of
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hearing [16-18].
The retrosigmoid approach for vestibular schwannomas provides panoramic visualization of the
cerebellopontine angle from the tentorium cerebelli to the foramen magnum. A retraction of
the temporal lobe of the brain is not required in the retrosigmoid approach. The main
disadvantage is the limited exposure of the internal auditory canal, hence, the lateral dissection
of the tumor is difficult [19]. The likelihood of hearing preservation becomes less if the tumor
infiltrates the cochlear nerve, preoperative hearing is poor, or the tumor size is large.
In recent years, some skull base surgeons started the use of endoscopes for the excision of the
tumors in the cerebellopontine angle. These endoscopic-assisted procedures are now gaining
popularity for the posterolateral skull base surgery [20].
The size of the tumor does not necessarily correlate with the presence of serviceable hearing at
the time of initial presentation [21]. This is also seen in 12 of our patients who had serviceable
hearing despite large grade 4 tumor size according to the Koos classification [22].
Injury to the facial nerve is one of the major complications with the surgical management of
vestibular schwannomas [23]. Facial nerve function is considered satisfactory as long as the
House-Brackmann Grade is 3 or less. The review of 89 articles on facial nerve function reported
78% of preservation with the retrosigmoid approach in tumor size of <20 mm and 67% in larger
tumors [24]. The facial nerve preservation rate in our study, where all patients had large tumors,
was 56% considering House-Brackmann Grade III or less as acceptable facial nerve function.
All patients were operated with the retrosigmoid approach in the standard position, as
described in the literature [25-26]. Significant variations have been reported regarding hearing
preservation after microsurgical resection of large vestibular schwannomas, ranging from 11%
to 70% [27-28]. In a study of 54 patients, preservation of hearing was reported in 53.7% of
patients with a size of more than 3 cm vestibular schwannomas [29]. In our study, we found 12
patients with serviceable hearing preoperatively and after surgery, seven out of those 12
patients had a serviceable hearing at the one-year follow-up. The hearing preservation rate in
our study was 58%, which is comparable to the percentages reported in the literature for large
vestibular schwannomas. The highest rate of a hearing preservation was reported in the middle
cranial fossa approach - as high as 70% in small tumors, which decreases to 50% as the tumor
size increases [30].
Conclusions
The optimal treatment for the small vestibular schwannoma is a matter of controversy;
however, the choice for the treatment of a large vestibular schwannoma in patients without
significant comorbidity is generally microsurgical excision. Surgical excision of a large VS with
the retrosigmoid approach is consistently found safe. The hearing and facial nerve preservation
in our study were found comparable with that in the literature.
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